Loading provider…
Loading provider…
Medical Oncology Physician in Orlando, FL
NPI: 1023194982Primary Practice Location
ORLANDO HEALTH
92 W Miller St, Orlando, FL
Primary Employer
Orlando Health Medical Group Inc
orlandohealth.com
HQ Phone
Get MD Yasser's Phone NumberMobile
Get MD Yasser's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2009 - 2027
TN State Medical License
2015 - 2024
MI State Medical License
2004 - 2014
TX State Medical License
1998 - 2005
VA State Medical License
1996 - 2000
GA State Medical License
1996 - 1997

American Board of Internal Medicine
Hematology
Westchester Medical Center
Fellowship • Hematology and Medical Oncology
1996 - 1999
Virginia Commonwealth University Health System
Fellowship • Hematology and Medical Oncology
1996 - 1997
SUNY Downstate Health Sciences University
downstate.edu
Residency • Internal Medicine
1993 - 1994
Other
Medical School
Until 1990
Cairo University School of Medicine
Medical School
Until 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 24 | 75 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 240 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 190 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 13 | 15 |
| 5 | 38222Bone marrow biopsy and aspiration | 13 | 21 |
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: National Cancer Institute (NCI), Blood and Marrow Transplant Clinical Trials Network
Intervention / Treatment: DRUG: Lenalidomide, DRUG: lenalidomide, bortezomib and dexamethasone
Lead Sponsor: Center for International Blood and Marrow Transplant Research
Collaborators: National Marrow Donor Program
Intervention / Treatment: DRUG: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Lead Sponsor: Paul Richardson, MD
Collaborators: University of California, San Diego, Emory University, University of California, San Francisco, Stanford University, University of Alabama at Birmingham, Ochsner Health System, Massachusetts General Hospital, University of Michigan, Columbia University, University of Chicago, Duke University, Millennium Pharmaceuticals, Inc., Celgene Corporation, Vanderbilt University Medical Center, Wake Forest University Health Sciences, M.D. Anderson Cancer Center, Huntsman Cancer Institute, Beth Israel Deaconess Medical Center, University of Florida, University of Mississippi Medical Center, Baylor College of Medicine, Icahn School of Medicine at Mount Sinai, Eastern Maine Medical Center, Ohio State University, City of Hope Medical Center, Fox Chase Cancer Center, University of Texas Southwestern Medical Center, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, University of Pittsburgh Medical Center, Northwell Health, Roswell Park Cancer Institute, University of Arizona, Fred Hutchinson Cancer Center, Cape Cod Hospital, Barbara Ann Karmanos Cancer Institute, UNC Lineberger Comprehensive Cancer Center, OHSU Knight Cancer Institute, State University of New York - Downstate Medical Center, Newton-Wellesley Hospital
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Dexamethasone, DRUG: Bortezomib, PROCEDURE: Autologous Stem Cell Transplant